WallStreetZenWallStreetZen

NASDAQ: OBIO
Orchestra Biomed Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Orchestra Biomed Holdings earnings were -$61.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest OBIO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$16.2M, up 4.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OBIO reported annual earnings of -$61.0M, with 24.2% growth.

OBIO earnings history

Current Revenue
$2.6M
Current Earnings
-$61.0M
Current Profit Margin
-2,313.3%

OBIO Return on Equity

Current Company
-135.2%
Current Industry
-2%
Current Market
34.1%
OBIO's Return on Equity (-135.2%)... subscribe to Premium to read more.
High Return on Equity Performance

OBIO undefined

Current Company
-79.6%
Current Industry
-0.4%
OBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OBIO announces earnings.

OBIO undefined

Current Company
-101.76%
Current Industry
5.9%
OBIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OBIO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OBIO-$60.06M-$61.02MN/A-$1.66
CSBR$8.10M$6.43M+282.31%$0.47
EDIT-$245.35M-$237.09MN/A-$2.88
NMRA-$239.69M-$243.79MN/A-$1.53
LXEO-$96.19M-$98.33MN/A-$3.09
View Top Biotech Stocks

Orchestra Biomed Holdings Earnings Reports & History FAQ

What were Orchestra Biomed Holdings's earnings last quarter?

Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q4 2024 earnings per share (EPS) of -$0.43, up 16.22% year over year. Total OBIO earnings for the quarter were -$16.16 million. In the same quarter last year, Orchestra Biomed Holdings's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.

Is Orchestra Biomed Holdings profitable or losing money?

As of the last Orchestra Biomed Holdings earnings report, Orchestra Biomed Holdings is currently losing money. Orchestra Biomed Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$61.02 million, a 24.23% increase year over year.

What was OBIO's earnings growth in the past year?

As of Orchestra Biomed Holdings's earnings date in Q2 2025, Orchestra Biomed Holdings's earnings has grown year over year. OBIO earnings in the past year totalled -$61.02 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.